Lessons from the Genetics of Colon Cancer

References

• Herrera L, Kakati S, Gibas L, Pietrzak E, Sandberg AA. Brief clinical report: Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 1986; 25: 473–176
   PubMed Web of Science ®Google Scholar
• Bodmer W F, Bailey C J, Bodmer J, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987; 328: 614–616
   PubMed Web of Science ®Google Scholar
• Leppert M, Dobbs M, Scambler P, et al. The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 1987; 238: 1411–1413
   PubMed Web of Science ®Google Scholar
• Khan P M, Tops C MJ, Broek M, Breukel C, et al. Close linkage of a highly polymorphic marker (D5S37) to familial adenomatous polyposis (FAP) and confirmation of FAP localization on chromosome 5q21-q22. Hum Genet 1988; 79: 183–185
   PubMed Web of Science ®Google Scholar
• Lynch H T, Lanspa S J, Boman B M, et al. Hereditary nonpolyposis colorectal cancer-Lynch syndromes I and II. Gastroent Clin N Am 1988; 17: 679–713
   PubMed Web of Science ®Google Scholar
• Lovett E. Family studies in cancer of the colon and rectum. Br J Surg 1976; 63: 13–18
   PubMed Web of Science ®Google Scholar
• Cannon-Albright L A, Skolnick M H, Bishop T, Lee R G, Burt RW. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med 1988; 319: 533–537
   PubMed Web of Science ®Google Scholar
• Kokal W, Scheibani K, Terz J, et al. Tumor DNA content in the prognosis of colorectal carcinoma. JAMA 1986; 255: 3123–3127
   PubMedGoogle Scholar
• Hiddemann W, Von Bassewitz D B, Kleinemeier H J, et al. DNA stemline heterogeneity in colorectal cancer. Cancer 1986; 58: 258–263
   PubMedGoogle Scholar
• Quirke P, Dixon M F, Clayden A D, et al. Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol 1987; 151: 285–291
   PubMed Web of Science ®Google Scholar
• Scott N A, Rainwater L M, Wieand H S, et al. The relative prognostic value of flow cytometric DNA analysis and conventional clinicopathologic criteria in patients with operable rectal carcinoma. Dis Col Rect 1987; 30: 513–520
   PubMedGoogle Scholar
• Schutte B, Reynders M J, Wiggers T, et al. Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma. Cancer Res 1987; 47: 5494–5496
   PubMedGoogle Scholar
• Scott N A, Wieand H S, Moertel C G, et al. Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern. Arch Surg 1987; 122: 1375–1379
   PubMed Web of Science ®Google Scholar
• Enblad P, Glimelius B, Bengtsson A, Ponten J, Pahlman L. The prognostic significance of DNA content in carcinoma of the rectum and rectosigmoid. Acta Chir Scand 1987; 153: 453–458
   PubMedGoogle Scholar
• Emdin S O, Stenling R, Roos G. Prognostic value of DNA content in colorectal carcinoma. A flow cytometric study with some methodologic aspects. Cancer 1987; 60: 1282–1287
   PubMedGoogle Scholar
• Rognum T O, Thorud E, Lund E. Survival of large bowel carcinoma patients with different DNA ploidy. Br J Cancer 1987; 56: 633–636
   PubMed Web of Science ®Google Scholar
• Jones D J, Moore M, Schofield PF. Prognostic significance of DNA ploidy in colorectal cancer: a prospective flow cytometric study. Br J Surg 1988; 75: 28–33
   PubMedGoogle Scholar
• Wiggers T, Arends J W, Schutte B, Volovicx L, Bosman FT. A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer 1988; 61: 386–395
   PubMed Web of Science ®Google Scholar
• Wolley R C, Schreiber K, Koss L G, Karas M, Sherman A. DNA distribution in human colon carcinomas and its relationship to clinical behavior. JNCI 1982; 69: 15–22
   PubMedGoogle Scholar
• Armitage N C, Robins R A, Evans D F, Turner D R, Baldwin R W, Hardcastle JD. The influence of tumor cell DNA abnormalities on survival in colorectal cancer. Br J Surg 1985; 72: 828–830
   PubMedGoogle Scholar
• Quirke P, Fozard J BJ, Dickson M F, Dyson J ED, Giles G R, Byrd CC. DNA aneuploidy in colorectal adenomas. Br J Cancer 1986; 53: 477–481
   PubMed Web of Science ®Google Scholar
• Petrova A S, Subrichina G N, Tschistjakova O V, et al. DNA ploidy and proliferation characteristics of bowel polyps analyzed by flow cytometry compared with cytology and histology. Arch Geschwulstforsch 1986; 56: S179–S191
   PubMedGoogle Scholar
• Hammarberg G, Slezak P, Tribukait B. Early detection of malignancy in ulcerative colitis. A flow-cytometric DNA study. Cancer 1984; 53: 191–195
   Google Scholar
• Friend S H, Dryja T P, Weinberg RA. Oncogenes and tumor-suppressing genes. N Engl J Med 1988; 318: 618–622
   PubMed Web of Science ®Google Scholar
• Chan V TW, McGee J OD. Cellular oncogenes in neoplasia. J Clin Pathol 1987; 40: 1055–1063
   PubMedGoogle Scholar
• Jones D J, Ghosh A K, Moore M, Schofield PF. A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer. Br J Cancer 1987; 56: 779–783
   PubMed Web of Science ®Google Scholar
• Alexander R J, Buxbaum J N, Raicht RF. Oncogene abnormalities in primary human colon tumours. Gastroenterology 1986; 91: 1503–1510
   PubMedGoogle Scholar
• Yokota J, Tsunetsugu-Yokota Y, Battifora H, LeFevrte C, Cline MJ. Alterations of myc, myb and ras proto-oncogenes in cancers are frequent and show clinical correlation. Science 1986; 231: 261–265
   PubMed Web of Science ®Google Scholar
• Yokota J, Yamamoto T, Toyoshima K, et al. Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet 1986; 1: 765–767
   PubMed Web of Science ®Google Scholar
• Erisman M D, Rothberg P G, Diehl R E, Morse C C, Spandorfer J M, Astrin SM. Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene. Mol Cell Biol 1985; 5: 1969–1976
   PubMed Web of Science ®Google Scholar
• Slamon D J, de Kernion J B, Verma J M, Cline MJ. Expression of cellular oncogenes in human malignancies. Science 1984; 224: 256–262
   PubMed Web of Science ®Google Scholar
• Calabretta B, Kaczmarek L, P-ML Ming, Au F, Ming S-C. Expression of c-myc and other cell cycle-dependent genes in human colon neoplasia. Cancer Res 1985; 45: 6000–6004
   PubMedGoogle Scholar
• Stewart J, Evan G, Watson J, Sikora K. Detection of the c-myc oncogene product in colonic polyps and carcinomas. Br J Cancer 1986; 53: 1–6
   PubMedGoogle Scholar
• Bos JL. The ras gene family and human carcinogenesis. Mutation Res 1988; 195: 255–271
   PubMed Web of Science ®Google Scholar
• Spandidos D A, Kerr IB. Elevated expression of the human ras oncogene family in premalignant and malignant tumours of the colorectum. Br J Cancer 1984; 49: 681–688
   PubMed Web of Science ®Google Scholar
• Monnat M, Tardy S, Saraga P, Diggelmann H, Costa J. Prognostic implications of expression of the cellular genes myc, fos, Ha-ras and Ki-ras in colon carcinoma. Br J Cancer 1987; 56: 293–299
   Google Scholar
• Bos J L, Fearon E R, Hamilton S R, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987; 327: 293–297
   PubMed Web of Science ®Google Scholar
• Forrester K, Almoguera C, Han K, Grizzel W E, Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987; 327: 298–303
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Fearon E R, Hamilton S R, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525–532
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Fearon E R, Kern S E, et al. Alle-lotype of colorectal carcinomas. Science 1989; 244: 207–211
   PubMed Web of Science ®Google Scholar
• Solomon E, Voss R, Hall V, et al. Chromosome 5 allele loss in human colorectal carcinomas. Nature 1987; 328: 616–619
   PubMed Web of Science ®Google Scholar
• Okamoto M, Sasaki M, Sugio K, et al. Loss of constitutional heterozygosity in colon carcinoma from patients with familial polyposis coli. Nature 1988; 331: 273–276
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Fearon E R, Hamilton S R, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525–530
   PubMed Web of Science ®Google Scholar
• Baker SJ, Fearon E R, Nigra J M, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989; 244: 271–221
   PubMedGoogle Scholar